A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

NCT03273842 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
422
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer